Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Century Huatong is a diversified Chinese technology group that has emerged as a leader in the digital therapeutics (DTx) and brain science sectors. Originally an automotive parts manufacturer that transitioned into a global gaming giant, the company now leverages its expertise in gamification and interactive software to develop clinical-grade medical interventions. Through its specialized digital medicine research institute and partnerships with institutions like Zhejiang University, Century Huatong develops products targeting neurodevelopmental and neurodegenerative disorders, including ADHD and autism. Their portfolio includes several NMPA-certified or clinically evaluated digital products designed to screen and treat cognitive impairments via interactive platforms. This unique intersection of entertainment technology and medical science positions the company at the forefront of the emerging digital medicine market in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Century Huatong.